Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer.

CONCLUSION: HDR-BRT with supplemental EBRT results in low biochemical relapse-free survival rates associated with a very low incidence of higher-grade late adverse events.
PMID: 29764692 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - May 12, 2018 Category: Radiology Authors: Strouthos I, Chatzikonstantinou G, Zamboglou N, Milickovic N, Papaioannou S, Bon D, Zamboglou C, Rödel C, Baltas D, Tselis N Tags: Radiother Oncol Source Type: research